The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer
Open accessAbstract
SLC7A11/xCT is an antiporter that mediates the uptake of extracellular cystine in exchange for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione synthesis; a process that protects cells from oxidative stress and is, therefore, critical to cell growth, proliferation, and metabolism. SLC7A11 is expressed in different tissues and plays diverse functional roles in the pathophysiology of various diseases, including cancer, by regulating the processes of redox homeostasis, metabolic flexibility/nutrient dependency, immune system function, and ferroptosis. SLC7A11 expression is associated with poor prognosis and drug resistance in cancer and, therefore, represents an important therapeutic target. In this review, we discuss the molecular functions of SLC7A11 in normal versus diseased tissues, with a special focus on how it regulates gastrointestinal cancers. Further, we summarize current therapeutic strategies targeting SLC7A11 as well as novel avenues for treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 1×
“Under certain nutrient deficient conditions, cancer cells undergo cell death whereas normal healthy cells survive because they are more metabolically flexible (45, 46).”
BackgroundTargeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Wang, W., Green, M., Choi, J. E., Gijón, M., Kennedy, P. D., Johnson, J. K., Liao, P., Lang, X., Kryczek, I., Sell, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1170-y · Cited by 2,880
The integrated stress response
Pakos‐Zebrucka, K., Koryga, I., Mnich, K., Ljujic, M., Samali, A., & Gorman, A. M. (2016) · The EMBO Reports · doi:10.15252/embr.201642195 · Cited by 2,659
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
Koppula, P., Zhuang, L., & Gan, B. (2021) · Protein & Cell · doi:10.1007/s13238-020-00789-5 · Cited by 2,487
Targeting Ferroptosis to Iron Out Cancer
Hassannia, B., Vandenabeele, P., & Vanden Berghe, T. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.04.002 · Cited by 2,478
Regulation of glutathione synthesis
Lu, S. C. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.05.005 · Cited by 2,116
Dixon, S. J., Patel, D. N., Welsch, M., Skouta, R., Lee, E. D., Hayano, M., Thomas, A. G., Gleason, C. E., Tatonetti, N. P., Slusher, B. S., et al. (2014) · eLife · doi:10.7554/elife.02523 · Cited by 2,088
NRF2 and the Hallmarks of Cancer
Rojo de la Vega, M., Chapman, E., & Zhang, D. D. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.022 · Cited by 1,672
Role of histone H2A ubiquitination in Polycomb silencing
Wang, H., Wang, L., Erdjument-Bromage, H., Vidal, M., Tempst, P., Jones, R. S., & Zhang, Y. (2004) · Nature · doi:10.1038/nature02985 · Cited by 1,663
Metabolic pathways promoting cancer cell survival and growth
Boroughs, L. K., & DeBerardinis, R. J. (2015) · Nature Cell Biology · doi:10.1038/ncb3124 · Cited by 1,462
Wilhelm, S. M., Adnane, L., Newell, P., Villanueva, A., Llovet, J. M., & Lynch, M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0013 · Cited by 1,459
Dolma, S., Lessnick, S. L., Hahn, W. C., & Stockwell, B. R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00050-3 · Cited by 1,446
The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression
Lei, G., Zhang, Y., Koppula, P., Liu, X., Zhang, J., Lin, S. H., Ajani, J. A., Xiao, Q., Liao, Z., Wang, H., et al. (2020) · Cell Research · doi:10.1038/s41422-019-0263-3 · Cited by 1,318
Cysteine depletion induces pancreatic tumor ferroptosis in mice
Badgley, M. A., Kremer, D. M., Maurer, H. C., DelGiorno, K. E., Lee, H.-J., Purohit, V., Sagalovskiy, I. R., Ma, A., Kapilian, J., Firl, C. E. M., et al. (2020) · Science · doi:10.1126/science.aaw9872 · Cited by 1,294
Self-citationGlutamine and cancer: cell biology, physiology, and clinical opportunities
Hensley, C. T., Wasti, A. T., & DeBerardinis, R. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69600 · Cited by 1,262
Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion
Friedmann Angeli, J. P., Krysko, D. V., & Conrad, M. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0149-1 · Cited by 1,259
Ishimoto, T., Nagano, O., Yae, T., Tamada, M., Motohara, T., Oshima, H., Oshima, M., Ikeda, T., Asaba, R., Yagi, H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.038 · Cited by 1,192 · cited 1×
“CD44v maintains SLC7A11 protein stability and CD44v deficiency compromises the cell surface localization of SLC7A11, resulting in ROS induction and inhibition of tumor formation (41, 42).”
BackgroundSato, H., Tamba, M., Ishii, T., & Bannai, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11455 · Cited by 1,109
Lang, X., Green, M. D., Wang, W., Yu, J., Choi, J. E., Jiang, L., Liao, P., Zhou, J., Zhang, Q., Dow, A., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0338 · Cited by 1,047
BAP1 links metabolic regulation of ferroptosis to tumour suppression
Zhang, Y., Shi, J., Liu, X., Feng, L., Gong, Z., Koppula, P., Sirohi, K., Li, X., Wei, Y., Lee, H., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0178-0 · Cited by 1,013
SULFUR AMINO ACID METABOLISM: Pathways for Production and Removal of Homocysteine and Cysteine
Stipanuk, M. H. (2004) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132418 · Cited by 995
Lewerenz, J., Hewett, S. J., Huang, Y., Lambros, M., Gout, P. W., Kalivas, P. W., Massie, A., Smolders, I., Methner, A., Pergande, M., et al. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4391 · Cited by 978
Koppula, P., Zhang, Y., Zhuang, L., & Gan, B. (2018) · Cancer Communications · doi:10.1186/s40880-018-0288-x · Cited by 915
Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence
Li, T., Kon, N., Jiang, L., Tan, M., Ludwig, T., Zhao, Y., Baer, R., & Gu, W. (2012) · Cell · doi:10.1016/j.cell.2012.04.026 · Cited by 912
ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway
Chu, B., Kon, N., Chen, D., Li, T., Liu, T., Jiang, L., Song, S., Tavana, O., & Gu, W. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0305-6 · Cited by 882
Kadoch, C., & Crabtree, G. R. (2015) · Science Advances · doi:10.1126/sciadv.1500447 · Cited by 828
Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB
Scheuermann, J. C., de Ayala Alonso, A. G., Oktaba, K., Ly-Hartig, N., McGinty, R. K., Fraterman, S., Wilm, M., Muir, T. W., & Müller, J. (2010) · Nature · doi:10.1038/nature08966 · Cited by 792
Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis
Fang, X., Cai, Z., Wang, H., Han, D., Cheng, Q., Zhang, P., Gao, F., Yu, Y., Song, Z., Wu, Q., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.316509 · Cited by 770
Oxygen Toxicity and Reactive Oxygen Species: The Devil Is in the Details
Auten, R. L., & Davis, J. M. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181a9eafb · Cited by 751
Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model
Zhang, Y., Tan, H., Daniels, J. D., Zandkarimi, F., Liu, H., Brown, L. M., Uchida, K., O'Connor, O. A., & Stockwell, B. R. (2019) · Cell Chemical Biology · doi:10.1016/j.chembiol.2019.01.008 · Cited by 721
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
Romero, R., Sayin, V. I., Davidson, S. M., Bauer, M. R., Singh, S. X., LeBoeuf, S. E., Karakousi, T. R., Ellis, D. C., Bhutkar, A., Sánchez-Rivera, F. J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4407 · Cited by 652
Weidinger, A., & Kozlov, A. (2015) · Biomolecules · doi:10.3390/biom5020472 · Cited by 646
The therapeutic promise of the cancer stem cell concept
Frank, N. Y., Schatton, T., & Frank, M. H. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41004 · Cited by 636
Iron‐dependent cell death of hepatocellular carcinoma cells exposed to sorafenib
Louandre, C., Ezzoukhry, Z., Godin, C., Barbare, J., Mazière, J., Chauffert, B., & Galmiche, A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28159 · Cited by 602
Conrad, M., & Sato, H. (2012) · Amino Acids · doi:10.1007/s00726-011-0867-5 · Cited by 598
ATF4-dependent transcription mediates signaling of amino acid limitation
Kilberg, M. S., Shan, J., & Su, N. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.05.008 · Cited by 591
Carbone, M., Yang, H., Pass, H. I., Krausz, T., Testa, J. R., & Gaudino, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3459 · Cited by 590
Liu, X., Olszewski, K., Zhang, Y., Lim, E. W., Shi, J., Zhang, X., Zhang, J., Lee, H., Koppula, P., Lei, G., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0496-x · Cited by 589
Sullivan, M. R., Danai, L. V., Lewis, C. A., Chan, S. H., Gui, D. Y., Kunchok, T., Dennstedt, E. A., Vander Heiden, M. G., & Muir, A. (2019) · eLife · doi:10.7554/elife.44235 · Cited by 588 · cited 1×
“Glucose and glutamine abundance are typically limited in the tumor microenvironment (59, 60).”
BackgroundTimmerman, L. A., Holton, T., Yuneva, M., Louie, R. J., Padró, M., Daemen, A., Hu, M., Chan, D. A., Ethier, S. P., van ‘t Veer, L. J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.020 · Cited by 573 · cited 2×
“This suggests that SLC7A11-high cancers, like TNBCs, are more dependent on glutamine (55).”
BackgroundMammalian Cysteine Metabolism: New Insights into Regulation of Cysteine Metabolism
Stipanuk, M. H., Dominy, J. E., Lee, J.-I., & Coloso, R. M. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.6.1652s · Cited by 543
Exchange of cystine and glutamate across plasma membrane of human fibroblasts.
Bannai, S. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35926-4 · Cited by 541
ROS in Cancer: The Burning Question
Chio, I. I. C., & Tuveson, D. A. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.03.004 · Cited by 532
Amino acid transporters revisited: New views in health and disease
Kandasamy, P., Gyimesi, G., Kanai, Y., & Hediger, M. A. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.05.003 · Cited by 484
Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors.
Lachaier, E., Louandre, C., Godin, C., Saidak, Z., Baert, M., Diouf, M., Chauffert, B., & Galmiche, A. (2014) · PubMed · Cited by 477
Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture.
Bannai, S., & Kitamura, E. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85901-x · Cited by 455
Breakdown of an Ironclad Defense System: The Critical Role of NRF2 in Mediating Ferroptosis
Anandhan, A., Dodson, M., Schmidlin, C. J., Liu, P., & Zhang, D. D. (2020) · Cell Chemical Biology · doi:10.1016/j.chembiol.2020.03.011 · Cited by 442
The chemistry and biology of ferroptosis
Stockwell, B. R., & Jiang, X. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.03.013 · Cited by 429 · cited 1×
“In contrast to NRF2 and ATF4, p53 has been shown to repress SLC7A11 expression, however, the mechanism is unclear (29, 30).”
BackgroundMetabolism of Amino Acids in Cancer
Wei, Z., Liu, X., Cheng, C., Yu, W., & Yi, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.603837 · Cited by 429
ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner
Chen, D., Fan, Z., Rauh, M., Buchfelder, M., Eyupoglu, I. Y., & Savaskan, N. (2017) · Oncogene · doi:10.1038/onc.2017.146 · Cited by 421 · cited 1×
“For example, we and others have observed that under cystine starvation conditions, pancreatic cancer cells upregulate SLC7A11 expression as a stress response (25).”
BackgroundHu, K., Li, K., Lv, J., Feng, J., Chen, J., Wu, H., Cheng, F., Jiang, W., Wang, J., Pei, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci124049 · Cited by 404
Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell
Yae, T., Tsuchihashi, K., Ishimoto, T., Motohara, T., Yoshikawa, M., Yoshida, G. J., Wada, T., Masuko, T., Mogushi, K., Tanaka, H., et al. (2012) · Nature Communications · doi:10.1038/ncomms1892 · Cited by 383
Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer
Roh, J.-L., Kim, E. H., Jang, H. J., Park, J. Y., & Shin, D. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.035 · Cited by 373
Jennis, M., Kung, C.-P., Basu, S., Budina-Kolomets, A., Leu, J. I.-J., Khaku, S., Scott, J. P., Cai, K. Q., Campbell, M. R., Porter, D. K., et al. (2016) · Genes & Development · doi:10.1101/gad.275891.115 · Cited by 352
xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
Ji, X., Qian, J., Rahman, S. M. J., Siska, P. J., Zou, Y., Harris, B. K., Hoeksema, M. D., Trenary, I. A., Heidi, C., Eisenberg, R., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0307-z · Cited by 350
xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling
Liu, J., Xia, X., & Huang, P. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.08.021 · Cited by 347
Cystine-Glutamate Transporter SLC7A11 in Cancer Chemosensitivity and Chemoresistance
Huang, Y., Dai, Z., Barbacioru, C., & Sadée, W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4267 · Cited by 340
Nakamura, E., Sato, M., Yang, H., Miyagawa, F., Harasaki, M., Tomita, K., Matsuoka, S., Noma, A., Iwai, K., & Minato, N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.3009 · Cited by 338
Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7A
Gao, W., Huang, Z., Duan, J., Nice, E. C., Lin, J., & Huang, C. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13079 · Cited by 333
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential
Wang, L., Leite de Oliveira, R., Huijberts, S., Bosdriesz, E., Pencheva, N., Brunen, D., Bosma, A., Song, J.-Y., Zevenhoven, J., Los-de Vries, G. T., et al. (2018) · Cell · doi:10.1016/j.cell.2018.04.012 · Cited by 327
The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death
Banjac, A., Perisic, T., Sato, H., Seiler, A., Bannai, S., Weiss, N., Kölle, P., Tschoep, K., Issels, R. D., Daniel, P. T., et al. (2008) · Oncogene · doi:10.1038/sj.onc.1210796 · Cited by 324
Muir, A., Danai, L. V., Gui, D. Y., Waingarten, C. Y., Lewis, C. A., & Vander Heiden, M. G. (2017) · eLife · doi:10.7554/elife.27713 · Cited by 311
Lim, J. K. M., Delaidelli, A., Minaker, S. W., Zhang, H.-F., Colovic, M., Yang, H., Negri, G. L., von Karstedt, S., Lockwood, W. W., Schaffer, P., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821323116 · Cited by 308
Shin, C.-S., Mishra, P., Watrous, J. D., Carelli, V., D’Aurelio, M., Jain, M., & Chan, D. C. (2017) · Nature Communications · doi:10.1038/ncomms15074 · Cited by 305
Koppula, P., Zhang, Y., Shi, J., Li, W., & Gan, B. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.798405 · Cited by 304
Robert, S. M., Buckingham, S. C., Campbell, S. L., Robel, S., Holt, K. T., Ogunrinu-Babarinde, T., Warren, P. P., White, D. M., Reid, M. A., Eschbacher, J. M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa8103 · Cited by 301
Galan-Cobo, A., Sitthideatphaiboon, P., Qu, X., Poteete, A., Pisegna, M. A., Tong, P., Chen, P.-H., Boroughs, L. K., Rodriguez, M. L. M., Zhang, W., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3527 · Cited by 292
Emerging roles for chromatin as a signal integration and storage platform
Badeaux, A. I., & Shi, Y. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3545 · Cited by 291 · cited 1×
“In addition to the transcriptional regulation of SLC7A11 under conditions of cell stress, SLC7A11 is also regulated via post-transcriptional mechanisms (5, 32).”
BackgroundTargeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers
Ogiwara, H., Takahashi, K., Sasaki, M., Kuroda, T., Yoshida, H., Watanabe, R., Maruyama, A., Makinoshima, H., Chiwaki, F., Sasaki, H., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2018.12.009 · Cited by 289
Transsulfuration Activity Can Support Cell Growth upon Extracellular Cysteine Limitation
Zhu, J., Berisa, M., Schwörer, S., Qin, W., Cross, J. R., & Thompson, C. B. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.009 · Cited by 286
Feng, L., Zhao, K., Sun, L., Yin, X., Zhang, J., Liu, C., & Li, B. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03042-7 · Cited by 277
The Non-Essential Amino Acid Cysteine Becomes Essential for Tumor Proliferation and Survival
Combs, J. A., & DeNicola, G. M. (2019) · Cancers · doi:10.3390/cancers11050678 · Cited by 272
SLC7A11/xCT in cancer: biological functions and therapeutic implications.
Lin, W., Wang, C., Liu, G., Bi, C., Wang, X., Zhou, Q., & Jin, H. (2020) · PubMed · Cited by 264
Guan, Z., Chen, J., Li, X., & Dong, N. (2020) · Bioscience Reports · doi:10.1042/bsr20201807 · Cited by 237
Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.
Stenson, W. F., & Lobos, E. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110474 · Cited by 229
Lo, M., Ling, V, Wang, Y. Z., & Gout, P. W. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604485 · Cited by 221
Drayton, R. M., Dudziec, E., Peter, S., Bertz, S., Hartmann, A., Bryant, H. E., & Catto, J. W. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2805 · Cited by 220
Slc7a11 gene controls production of pheomelanin pigment and proliferation of cultured cells
Chintala, S., Li, W., Lamoreux, M. L., Ito, S., Wakamatsu, K., Sviderskaya, E. V., Bennett, D. C., Park, Y.-M., Gahl, W. A., Huizing, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502856102 · Cited by 213
Nrf2 and STAT3 Alleviates Ferroptosis-Mediated IIR-ALI by Regulating SLC7A11
Qiang, Z., Dong, H., Xia, Y., Chai, D., Hu, R., & Jiang, H. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5146982 · Cited by 212
Gu, Y., Albuquerque, C. P., Braas, D., Zhang, W., Villa, G. R., Bi, J., Ikegami, S., Masui, K., Gini, B., Yang, H., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.030 · Cited by 208
Daher, B., Parks, S. K., Durivault, J., Cormerais, Y., Baidarjad, H., Tambutte, E., Pouysségur, J., & Vučetić, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3855 · Cited by 200
Liu, X.-X., Li, X.-J., Zhang, B., Liang, Y.-J., Zhou, C.-X., Cao, D.-X., He, M., Chen, G.-Q., He, J.-R., & Zhao, Q. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.018 · Cited by 194
De Bundel, D., Schallier, A., Loyens, E., Fernando, R., Miyashita, H., Van Liefferinge, J., Vermoesen, K., Bannai, S., Sato, H., Michotte, Y., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5465-10.2011 · Cited by 193
Robe, P. A., Martin, D. H., Nguyen-Khac, M. T., Artesi, M., Deprez, M., Albert, A., Vanbelle, S., Califice, S., Bredel, M., & Bours, V. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-372 · Cited by 186
MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis
Ni, H., Qin, H., Sun, C., Liu, Y., Ruan, G., Guo, Q., Xi, T., Xing, Y., & Zheng, L. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02394-7 · Cited by 181
He, Q., Liu, M., Huang, W., Chen, X., Zhang, B., Zhang, T., Wang, Y., Liu, D., Xie, M., Ji, X., et al. (2021) · Hepatology · doi:10.1002/hep.32062 · Cited by 177
HBx facilitates ferroptosis in acute liver failure via EZH2 mediated SLC7A11 suppression
Liu, G., Xu, X., Tao, S.-H., Gao, M.-J., & Hou, Z. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00762-2 · Cited by 175
Olm, E., Fernandes, A. P., Hebert, C., Rundlöf, A.-K., Larsen, E. H., Danielsson, O., & Björnstedt, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902204106 · Cited by 173
Bassi, M., Gasol, E., Manzoni, M., Pineda, M., Riboni, M., Martín, R., Zorzano, A., Borsani, G., & Palacín, M. (2001) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s004240100537 · Cited by 171
Recent developments in the role of reactive oxygen species in allergic asthma
Qu, J., Li, Y., Zhong, W., Gao, P., & Hu, C. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.01.05 · Cited by 170
Patel, S. A., Warren, B. A., Rhoderick, J. F., & Bridges, R. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.08.006 · Cited by 164
Xu, X., Zhang, X., Wei, C., Zheng, D., Lü, X., Yang, Y., Luo, A., Zhang, K., Duan, X., & Wang, Y. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105450 · Cited by 163
Polewski, M. D., Reveron‐Thornton, R. F., Cherryholmes, G. A., Marinov, G. K., Cassady, K. M., & Aboody, K. S. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0028 · Cited by 151
IMCA Induces Ferroptosis Mediated by SLC7A11 through the AMPK/mTOR Pathway in Colorectal Cancer
Zhang, L., Liu, W., Liu, F., Wang, Q., Song, M., Yu, Q., Tang, K., Teng, T., Wu, D., Wang, X.-J., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1675613 · Cited by 148
Sharbeen, G., McCarroll, J. A., Akerman, A., Kopecky, C., Youkhana, J., Kokkinos, J., Holst, J., Boyer, C. A., Erkan, M., Goldstein, D., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2496 · Cited by 144
Regulation of H2A ubiquitination and SLC7A11 expression by BAP1 and PRC1
Zhang, Y., Koppula, P., & Gan, B. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1597506 · Cited by 141
Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma
Guo, W., Zhao, Y., Zhang, Z., Tan, N., Zhao, F., Ge, C., Liang, L., Jia, D., Chen, T., Yao, M., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.07.024 · Cited by 134
Lanzardo, S., Conti, L., Rooke, R., Ruiu, R., Accart, N., Bolli, E., Arigoni, M., Macagno, M., Barrera, G., Pizzimenti, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1208 · Cited by 134
Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite
Gu, X., El‐Remessy, A. B., Brooks, S. E., Al‐Shabrawey, M., Tsai, N. –., & Caldwell, R. B. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00424.2002 · Cited by 125
MiR‐375/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion
Wu, Y., Sun, X., Song, B., Qiu, X., & Zhao, J. (2017) · Cancer Medicine · doi:10.1002/cam4.1110 · Cited by 119
Tsuchihashi, K., Okazaki, S., Ohmura, M., Ishikawa, M., Sampetrean, O., Onishi, N., Wakimoto, H., Yoshikawa, M., Seishima, R., Iwasaki, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2121 · Cited by 115
Bannai, S., & Ishii, T. (1988) · Journal of Cellular Physiology · doi:10.1002/jcp.1041370221 · Cited by 114
Lidocaine Promoted Ferroptosis by Targeting miR-382-5p /SLC7A11 Axis in Ovarian and Breast Cancer
Sun, D., Li, Y.-C., & Zhang, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.681223 · Cited by 111
Joly, J. H., Delfarah, A., Phung, P. S., Parrish, S., & Graham, N. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011471 · Cited by 105
Liu, Y., Song, Z., Liu, Y., Ma, X., Wang, W., Ke, Y., Xu, Y., Yu, D., & Liu, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.006 · Cited by 105
Joly, J. H., Delfarah, A., Phung, P. S., Parrish, S., & Graham, N. A. (2020) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)49891-7 · Cited by 102
Kou, L., Sun, R., Xiao, S., Zheng, Y., Chen, Z., Cai, A., Zheng, H., Yao, Q., Ganapathy, V., & Chen, R. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b09784 · Cited by 101
BAP1 suppresses tumor development by inducing ferroptosis upon SLC7A11 repression
Zhang, Y., Zhuang, L., & Gan, B. (2018) · Molecular & Cellular Oncology · doi:10.1080/23723556.2018.1536845 · Cited by 97
Khamari, R., Trinh, A., Gabert, P.-E., Corazao-Rozas, P., Riveros-Cruz, S., Balayssac, S., Malet‐Martino, M., Dekiouk, S., Curt, M. J.-C., Maboudou, P., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0340-4 · Cited by 92
Tang, R., Hua, J., Xu, J., Liang, C., Meng, Q., Liu, J., Zhang, B., Yu, X., & Shi, S. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-2554a · Cited by 90
Ju, H., Lu, Y., Chen, D.-L., Tian, T., Mo, H., Wei, X., Liao, J.-W., Wang, F., Zeng, Z.-L., Pelicano, H., et al. (2016) · Theranostics · doi:10.7150/thno.14848 · Cited by 87
Effective ferroptotic small-cell lung cancer cell death from SLC7A11 inhibition by sulforaphane
Iida, Y., Okamoto-Κatsuyama, M., Maruoka, S., Mizumura, K., Shimizu, T., Shikano, S., Hikichi, M., Takahashi, M., Tsuya, K., Okamoto, S., et al. (2020) · Oncology Letters · doi:10.3892/ol.2020.12332 · Cited by 87
Wada, F., Koga, H., Akiba, J., Niizeki, T., Iwamoto, H., Ikezono, Y., Nakamura, T., Abe, M., Masuda, A., Sakaue, T., et al. (2018) · Cancer Science · doi:10.1111/cas.13728 · Cited by 81
Zhu, J.-H., de Mello, R. A., Yan, Q., Wang, J., Chen, Y., Ye, Q., Wang, Z., Tang, H., & Huang, T. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165747 · Cited by 80
Ye, J., Jiang, X., Dong, Z., Hu, S., & Xiao, M. (2019) · Cancer Management and Research · doi:10.2147/cmar.s217944 · Cited by 78
Zhang, L., Huang, Y., Ling, J., Zhuo, W., Yu, Z., Luo, Y., & Zhu, Y. (2018) · Future Oncology · doi:10.2217/fon-2017-0540 · Cited by 76
He, J., Ding, H., Li, H., Pan, Z., & Chen, Q. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.770857 · Cited by 76
xCT (SLC7A11) expression confers intrinsic resistance to physical plasma treatment in tumor cells
Bekeschus, S., Eisenmann, S., Sagwal, S. K., Bodnar, Y., Moritz, J., Poschkamp, B., Stoffels, I., Emmert, S., Madesh, M., Weltmann, K., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101423 · Cited by 72
Bolli, E., O’Rourke, J. P., Conti, L., Lanzardo, S., Rolih, V., Christen, J. M., Barutello, G., Forni, M., Pericle, F., & Cavallo, F. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1408746 · Cited by 71
Du, K., Oh, S., Dutta, R. K., Sun, T., Yang, W., Chi, J., & Diehl, A. M. (2021) · Liver International · doi:10.1111/liv.14945 · Cited by 67
Levobupivacaine Induces Ferroptosis by miR-489-3p/SLC7A11 Signaling in Gastric Cancer
Mao, S., Zhu, C., Nie, Y., Yu, J., & Wang, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.681338 · Cited by 67
Liang, Y., Ye, F., Xu, C., Zou, L., Hu, Y. Y., Hu, J., & Jiang, H. (2021) · BMC Cancer · doi:10.1186/s12885-021-08687-7 · Cited by 64
Prognostic and Immunological Role of Key Genes of Ferroptosis in Pan-Cancer
Shi, Z., Tao, H., Fan, Z.-W., Song, S.-J., & Bai, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.748925 · Cited by 64
Participation of xCT in melanoma cell proliferation in vitro and tumorigenesis in vivo
Shin, S., Jeong, B., Wall, B., Li, J., Shan, N. L., Wen, Y., Goydos, J. S., & Chen, S. (2018) · Oncogenesis · doi:10.1038/s41389-018-0098-7 · Cited by 63
Wang, S., Wung, C.-H., Chen, M.-S., Chen, C., Yin, P., Yeh, T.-S., Chang, Y.-L., Chou, Y., Hung, H.-H., & Lee, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113389 · Cited by 62
Ogihara, K., Kikuchi, E., Okazaki, S., Hagiwara, M., Takeda, T., Matsumoto, K., Kosaka, T., Mikami, S., Saya, H., & Oya, M. (2019) · Cancer Science · doi:10.1111/cas.13960 · Cited by 60
Zhao, X., Li, Y., & Wu, H. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3739 · Cited by 55
Cystine/Glutamate Antiporter (xCT) Is Required for Chief Cell Plasticity After Gastric Injury
Meyer, A. R., Engevik, A. C., Willet, S. G., Williams, J. A., Zou, Y., Massion, P. P., Mills, J. C., Choi, E.-Y. K., & Goldenring, J. R. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.04.015 · Cited by 51
Shen, L., Qian, C., Cao, H., Wang, Z., Luo, T., & Liang, C. (2018) · World Journal of Surgical Oncology · doi:10.1186/s12957-018-1535-y · Cited by 50
Liu, R., Blower, P. E., Pham, A., Fang, J., Dai, Z., Wise, C., Green, B., Teitel, C. H., Ning, B., Ling, W., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.039644 · Cited by 46
Systematic analyses of glutamine and glutamate metabolisms across different cancer types
Tian, Y., Du, W., Cao, S., Wu, Y., Dong, N., Wang, Y., & Xu, Y. (2017) · 癌症:英文版 · doi:10.1186/s40880-017-0255-y · Cited by 45
Donofrío, G., Tebaldi, G., Lanzardo, S., Ruiu, R., Bolli, E., Ballatore, A., Rolih, V., Macchi, F., Conti, L., & Cavallo, F. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1494108 · Cited by 45
Luo, Y., Wang, C., Yong, P., Ye, P., Li, H., Fu, Z., Lu, F., Xiang, W., Wang, T., & Xiao, J. (2017) · Oncotarget · doi:10.18632/oncotarget.22486 · Cited by 42
Behavioral characterization of system xc- mutant mice
McCullagh, E. A., & Featherstone, D. E. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.02.010 · Cited by 41
Extracellular redox state shift: A novel approach to target prostate cancer invasion
Zhong, W., Weiss, H. L., Jayswal, R. D., Hensley, P. J., Downes, L. M., Clair, D. K. S., & Chaiswing, L. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.01.023 · Cited by 40
TRAP-seq identifies cystine/glutamate antiporter as a driver of recovery from liver injury
Wang, A. W., Wangensteen, K. J., Wang, Y. J., Zahm, A. M., Moss, N., Noam Erez, A., & Kaestner, K. H. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95120 · Cited by 33
Identification of capsazepine as a novel inhibitor of system xc− and cancer-induced bone pain
Fazzari, J., Balenko, M. D., Zacal, N., & Singh, G. (2017) · Journal of Pain Research · doi:10.2147/jpr.s125045 · Cited by 29
Otto, A. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.596197 · Cited by 29
JNK activation mediates the apoptosis of xCT-deficient cells
Qiao, H., Hao, C., Li, Y., He, X., Chen, R.-S., Cui, J., Xu, Z., & Li, W. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.134 · Cited by 23
Sprimont, L., Janssen, P., Swert, K. D., Bulck, M. V., Rooman, I., Gilloteaux, J., Massie, A., & Nicaise, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-91698-y · Cited by 17
Shiromizu, S., Yamauchi, T., Kusunose, N., Matsunaga, N., Koyanagi, S., & Ohdo, S. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00546 · Cited by 16
Cited by
Targeting glutamine metabolism as a therapeutic strategy for cancer
Jin, J., Byun, J.-K., Choi, Y.-K., & Park, K.-G. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00971-9 · Cited by 550
Overcoming cancer chemotherapy resistance by the induction of ferroptosis
Wang, Y., Wu, X., Ren, Z., Li, Y., Zou, W., Chen, J., & Wang, H. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100916 · Cited by 361
Diversity and complexity of cell death: a historical review
Park, W., Wei, S., Kim, B.-S., Kim, B., Bae, S.-J., Chae, Y. C., Ryu, D., & Ha, K.-T. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01078-x · Cited by 342
Metabolic reprogramming: The driving force behind cancer drug resistance
El-Sehrawy, A. A. M. A., Hsu, C.-Y., Alkhathami, A. G., Chandra, M., Basunduwah, T. S., Malathi, H., Senapati, J. N., Gautam, A., Kadhem, M., & Yasin, H. A. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152392 · Cited by 11
Metadata
- Authors
- Jyotsana, N., Ta, K. T., & DelGiorno, K. E.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2022-02-23
- Volume
- 12
- Pages
- 858462-858462
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W4214539320
- Cited by
- 272
- References
- 145
- FWCI
- 17.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.